NKT and Tolerance

Methods in Molecular Biology

Volumn 677, Issue , 2011, Pages 193-206

  Diana, Julien ^a,b   Beaudoin, Lucie ^a,b   Gautron, Anne Sophie ^a,b   Lehuen, Agnès ^a,b  

^a Hôpital Cochin/St Vincent de Paul ^*  (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Cytokine; Dendritic cell; Immunoregulation; NKT; Suppressive; GalCer

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; ALPHA-GALACTOSYLCERAMIDE; CD14 ANTIGEN; CD1D ANTIGEN; CYTOKINE; GALACTOSYLCERAMIDE; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CELL CULTURE; DENDRITIC CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD14; ANTIGENS, CD1D; B-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; GALACTOSYLCERAMIDES; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; NATURAL KILLER T-CELLS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTE SUBSETS;

EID: 79952196838     PISSN: 10643745     EISSN: 19406029     Source Type: Book Series    
DOI: 10.1007/978-1-60761-869-0_14     Document Type: Chapter

References (21)

1. Kronenberg, M. and L. Gapin (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol. 2(8): p. 557–68.
2. Bendelac, A., P.B. Savage and L. Teyton (2007) The biology of NKT cells. Annu Rev Immunol. 25: p. 297–336.
3. Mendiratta, S.K., W.D. Martin, S. Hong, et al. (1997) CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6(4): p. 469–77.
4. Cui, J., T. Shin, T. Kawano, et al. (1997) Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors. Science. 278(5343): p. 1623–6.
5. Bendelac, A., R.D. Hunziker and O. Lantz (1996) Increased interleukin 4 and immunoglobulin E production in transgenic mice overexpressing NK1 T cells. J Exp Med. 184(4): p. 1285–93.
6. Lehuen, A., O. Lantz, L. Beaudoin, et al. (1998) Overexpression of natural killer T cells protects Valpha14-Jalpha281 transgenic nonobese diabetic mice against diabetes. J Exp Med. 188(10): p. 1831–9.
7. Duarte, N., M. Stenstrom, S. Campino, et al. (2004) Prevention of diabetes in nonobese diabetic mice mediated by CD1d-restricted nonclassical NKT cells. J Immunol. 173(5): p. 3112–8.
8. Skold, M., N.N. Faizunnessa, C.R. Wang, et al. (2000) CD1d-specific NK1.1+ T cells with a transgenic variant TCR. J Immunol. 165(1): p. 168–74.
9. Benlagha, K., A. Weiss, A. Beavis, et al. (2000) In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med. 191(11): p. 1895–903.
10. Matsuda, J.L., O.V. Naidenko, L. Gapin, et al. (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med. 192(5): p. 741–54.
11. Mars, L.T., A.S. Gautron, J. Novak, et al. (2008) Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner. J Immunol. 181(4): p. 2321–9.
12. Beaudoin, L., V. Laloux, J. Novak, et al. (2002) NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity. 17(6): p. 725–36.
13. Novak, J., L. Beaudoin, T. Griseri, et al. (2005) Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts. J Immunol. 174(4): p. 1954–61.
14. Brossay, L., M. Chioda, N. Burdin, et al. (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med. 188(8): p. 1521–8.
15. Casorati, G., A. Traunecker and K. Karjalainen (1993) The T cell receptor alpha beta V-J shuffling shows lack of autonomy between the combining site and the constant domain of the receptor chains. Eur J Immunol. 23(2): p. 586–9.
16. Diana, J., T. Griseri, S. Lagaye, et al. (2009) NKT Cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity. 30(2): p. 289–99.
17. Laloux, V., L. Beaudoin, C. Ronet, et al. (2002) Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes. J Immunol. 168(7): p. 3251–8.
18. Wei, D.G., H. Lee, S.H. Park, et al. (2005) Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes. J Exp Med. 202(2): p. 239–48.
19. Novak, J., L. Beaudoin, S. Park, et al. (2007) Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J Immunol. 178(3): p. 1332–40.
20. Schumann, J., P. Pittoni, E. Tonti, et al. (2005) Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells. J Immunol. 175(11): p. 7303–10.
21. Abrignani, S., E. Tonti, G. Casorati, et al. (2009) B cell helper assays. Methods Mol Biol. 514: p. 15–26.